Xiu YL - Search Results

1

Inhibition of Ovarian Epithelial Carcinoma Tumorigenesis and Progression by microRNA 106b Mediated through the RhoC Pathway.

Chen S, Chen X, Xiu YL, Sun KX, Zhao Y. Chen S, et al. Among authors: xiu yl. PLoS One. 2015 May 1;10(5):e0125714. doi: 10.1371/journal.pone.0125714. eCollection 2015. PLoS One. 2015. PMID: 25933027 Free PMC article.

2

BTG1 expression correlates with the pathogenesis and progression of ovarian carcinomas.

Zhao Y, Gou WF, Chen S, Takano Y, Xiu YL, Zheng HC. Zhao Y, et al. Among authors: xiu yl. Int J Mol Sci. 2013 Sep 27;14(10):19670-80. doi: 10.3390/ijms141019670. Int J Mol Sci. 2013. PMID: 24084718 Free PMC article.

3

Anacardic acid enhances the proliferation of human ovarian cancer cells.

Xiu YL, Zhao Y, Gou WF, Chen S, Takano Y, Zheng HC. Xiu YL, et al. PLoS One. 2014 Jun 12;9(6):e99361. doi: 10.1371/journal.pone.0099361. eCollection 2014. PLoS One. 2014. PMID: 24921663 Free PMC article.

4

The role of RhoC in epithelial-to-mesenchymal transition of ovarian carcinoma cells.

Gou WF, Zhao Y, Lu H, Yang XF, Xiu YL, Zhao S, Liu JM, Zhu ZT, Sun HZ, Liu YP, Xu F, Takano Y, Zheng HC. Gou WF, et al. Among authors: xiu yl. BMC Cancer. 2014 Jul 1;14:477. doi: 10.1186/1471-2407-14-477. BMC Cancer. 2014. PMID: 24986540 Free PMC article.

5

microRNA 490-3P enhances the drug-resistance of human ovarian cancer cells.

Chen S, Chen X, Xiu YL, Sun KX, Zong ZH, Zhao Y. Chen S, et al. Among authors: xiu yl. J Ovarian Res. 2014 Aug 31;7:84. doi: 10.1186/s13048-014-0084-4. J Ovarian Res. 2014. PMID: 25297343 Free PMC article.

6

RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression.

Chen X, Chen S, Xiu YL, Sun KX, Zong ZH, Zhao Y. Chen X, et al. Among authors: xiu yl. Mol Cancer. 2015 Feb 4;14(1):31. doi: 10.1186/s12943-015-0304-6. Mol Cancer. 2015. PMID: 25649143 Free PMC article.

7

MicroRNA-490-3P targets CDK1 and inhibits ovarian epithelial carcinoma tumorigenesis and progression.

Chen S, Chen X, Xiu YL, Sun KX, Zhao Y. Chen S, et al. Among authors: xiu yl. Cancer Lett. 2015 Jun 28;362(1):122-30. doi: 10.1016/j.canlet.2015.03.029. Epub 2015 Mar 25. Cancer Lett. 2015. PMID: 25819031

8

Erratum to: microRNA 490-3P enhances the drug-resistance of human ovarian cancer cells.

Chen S, Chen X, Xiu YL, Sun KX, Zong ZH, Zhao Y. Chen S, et al. Among authors: xiu yl. J Ovarian Res. 2015 Dec 1;8:79. doi: 10.1186/s13048-015-0194-7. J Ovarian Res. 2015. PMID: 26626309 Free PMC article. No abstract available.

9

MiR-23b targets cyclin G1 and suppresses ovarian cancer tumorigenesis and progression.

Yan J, Jiang JY, Meng XN, Xiu YL, Zong ZH. Yan J, et al. Among authors: xiu yl. J Exp Clin Cancer Res. 2016 Feb 13;35:31. doi: 10.1186/s13046-016-0307-1. J Exp Clin Cancer Res. 2016. PMID: 26872615 Free PMC article.

10

MicroRNA-93 Promotes Epithelial-Mesenchymal Transition of Endometrial Carcinoma Cells.

Chen S, Chen X, Sun KX, Xiu YL, Liu BL, Feng MX, Sang XB, Zhao Y. Chen S, et al. Among authors: xiu yl. PLoS One. 2016 Nov 9;11(11):e0165776. doi: 10.1371/journal.pone.0165776. eCollection 2016. PLoS One. 2016. PMID: 27829043 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25 results

Search Page

Filters